Financhill
Back

Range Cancer Therapeutics ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
7

CNCR
Range Cancer Therapeutics ETF

Last Price:
$11.00
Seasonality Move:
-3.32%
Buy
54

SRPT
Sarepta Therapeutics

Last Price:
$99.80
Seasonality Move:
6.73%
Sell
7
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $10.83. The Score for CNCR is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $10.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $100.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 36.15 Sell
Chaikin Money Flow: 2685 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.24 - 12.56) Sell
Bollinger Bands (100): (11.84 - 14.56) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.22 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: 544784 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.87 - 112.63) Sell
Bollinger Bands (100): (110.05 - 127.23) Sell

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.04 Sell
20-day SMA: 11.78 Sell
50-day SMA: 12.09 Sell
200-day SMA: 13.91 Sell
8-day EMA: 11.15 Sell
20-day EMA: 11.58 Sell
50-day EMA: 12.17 Sell
200-day EMA: 13.46 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.91 Sell
20-day SMA: 106.68 Sell
50-day SMA: 114.29 Sell
200-day SMA: 126.68 Sell
8-day EMA: 104.06 Sell
20-day EMA: 106.89 Sell
50-day EMA: 112.29 Sell
200-day EMA: 121 Sell

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):